glp-1 weight loss drug news today october 2025 Rhode Island considers ending Medicaid coverage of drugs for • Rhode Island Current As the use of GLP-1
Description
The pharmaceutical industry, represented by the trade organization PhRMA, would like to see Medicare rules changed to allow more patients to take the drugs and is pushing for more oversight and reining in of some of the compounding pharmacies that sell GLP-1 drugs directly to consumers
Given the shift towards pharmaceutical intervention in obesity management, GLP-1 therapies are expected to account for a substantial share of this growth
As well as hospitals with specialized care and treatment strategies for patients with complex medical requirements, generating a key setting for GLP-1 receptor agonist distribution
doi: 10.7570/jomes20059 21 LeonNLaCoursiereRYaroshDPatelRS
Tamborlane WV, Barrientos-Perez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al
